CBIONasdaq United States
Market cap
$625.504 M
$16.84 +2.50%
Close of 7 Aug 2026
Revenue
$10.8M
#3159 by revenue
Earnings
$153.9K
#2452 by earnings
Shares outstanding
37,143,940
Latest filing cover page
P/E ratio
4063.2
Cap ÷ net income
Where these numbers come from
Share counts and financials for Crescent Biopharma are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.